Dose-dependent Effects of Second-hand Smoke on Vascular Function
This study has been completed.
Sponsor:
University of California, San Francisco
Information provided by:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01007760
First received: November 3, 2009
Last updated: July 18, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the vascular effects of brief second-hand smoke exposure on normal healthy individuals.
| Condition | Intervention |
|---|---|
|
Cardiovascular Disease |
Other: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Basic Science |
| Official Title: | Dose-dependent Biological Mechanisms of Second-hand Smoke on Endothelial Function and Oxidative Stress |
Resource links provided by NLM:
Further study details as provided by University of California, San Francisco:
Primary Outcome Measures:
- Brachial Artery Flow-mediated dilation (FMD) [ Time Frame: Same day - before/after exposure ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Plasma measurement of asymmetric dimethylarginine (ADMA) and Nitrotyrosine levels [ Time Frame: Same day - before/after exposure ] [ Designated as safety issue: No ]
| Enrollment: | 33 |
| Study Start Date: | November 2009 |
| Study Completion Date: | July 2011 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Placebo Comparator: Room air |
Other: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
acute one time exposure
Other Name: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
|
| Active Comparator: Low dose exposure second-hand smoke |
Other: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
acute one time exposure
Other Name: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
|
| Active Comparator: High dose exposure second-hand smoke |
Other: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
acute one time exposure
Other Name: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
|
Detailed Description:
Second-hand smoke remains a significant public health threat. Despite evidence to suggest that secondhand smoke contributes to adverse cardiovascular outcomes, little is known about the dose-dependent vascular effects of brief secondhand smoke exposure at low doses commonly encountered in the community. This study will investigate the acute vascular effects and dose-dependent biological mechanisms of secondhand smoke on endothelial function and oxidative stress.
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Healthy non-smoking adults
Exclusion Criteria:
- Reported Active Smoking
- History of diabetes, hypertension, chronic respiratory disease, coronary artery disease, prior myocardial infarction or heart failure
- Pregnancy or breastfeeding
- Current use of prescription drugs within 14 days of trial
- Reported significant passive smoke exposure or elevated cotinine levels
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01007760
Locations
| United States, California | |
| UCSF San Francisco General Hospital | |
| San Francisco, California, United States, 94110 | |
Sponsors and Collaborators
University of California, San Francisco
Investigators
| Principal Investigator: | Peter Ganz, MD | UCSF San Francisco General Hospital |
More Information
No publications provided
| Responsible Party: | Peter Ganz, M.D., UCSF |
| ClinicalTrials.gov Identifier: | NCT01007760 History of Changes |
| Other Study ID Numbers: | TRDRP-18FT-0049 |
| Study First Received: | November 3, 2009 |
| Last Updated: | July 18, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, San Francisco:
|
Tobacco smoke Oxidative stress Endothelial Function |
Atherosclerosis Arterial Stiffness Microvascular Function |
Additional relevant MeSH terms:
|
Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013